Finally, Rhizoma Drynariae-derived EVs exhibited potent bone tissue-targeting activity and anti-osteoporosis efficacy in an ovariectomized mouse model, and potentiated osteogenic differentiation of human bone MSCs by targeting estrogen receptor-alpha (ERα) [61]. The gene discussed is ESR1; the disease is osteoporosis.